One more strike against diabetes drugs. Australia's regulators are warning that the class of drugs including Avandia and Actos may boost the risk of bone fractures in older women.

A four-year study of 4,360 patients showed that post-menopausal women taking one of the thiazolidinediones were more likely to break a bone. The Therapeutic Goods Administration won't withdraw the drugs, but manufacturers are warning doctors about the newly identified risks.

- read the report [1] from the Sydney Morning Herald

Related Articles:
Avandia, Actos don't boost death risk. Report [1]
Actos on a good-news roll. Report [1]
Avandia risks back in the headlines. Report [1]
Australia bans Novartis' Prexige. Report [1]